Ozempic maker Novo Nordisk failed to disclose millions it paid to healthcare groups - watchdog
Novo Nordisk - which manufactures Wegovy, Ozempic and Saxenda - misreported, under-reported or did not disclose funding it ...
Novo Nordisk shares surge on results of new obesity drug trial
Novo Nordisk announced positive trial results for its next-generation obesity drug, leading to a 7.13% surge in its share ...
nyheder.tv29h
Novos store konkurrent spiser middag med Trump – bør Danmark være bekymret?
Novo Nordisks værdi på aktiemarkedet er blevet næsten halveret de seneste seks måneder. Men selskabet er ikke i krise, siger ...
This Wegovy user spent $5,000 on a new wardrobe after losing 80 pounds - and she's not alone
Tori Allen says she's thrilled to have lost 80 pounds since she went on Wegovy, one of the GLP-1 drugs that more and more people are using to treat diabetes or lose weight.
pharmaphorum17h
Lilly’s Mounjaro wins latest head-to-head battle in clinical trials of diabetes treatments
Mounjaro, manufactured by Lilly, may have emerged as the newest and most effective treatment option after a victory over Novo Nordisk’s Ozempic in clinical trials. For some patients, injectables ...
Pharma is hopeful about Trump's second term — here's what to expect for drugmakers
Drugmakers hope to see efforts that focus more on cracking down on pharmacy benefit managers while promoting drug innovation ...